Annual Retained Earnings
-$142.20 M
-$35.20 M-32.89%
December 31, 2023
Summary
- As of February 8, 2025, ELTX annual retained earnings is -$142.20 million, with the most recent change of -$35.20 million (-32.89%) on December 31, 2023.
- During the last 3 years, ELTX annual retained earnings has fallen by -$89.80 million (-171.38%).
- ELTX annual retained earnings is now -287.60% below its all-time high of -$36.69 million, reached on December 31, 2019.
Performance
ELTX Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Retained Earnings
-$180.10 M
-$18.84 M-11.68%
September 30, 2024
Summary
- As of February 8, 2025, ELTX quarterly retained earnings is -$180.10 million, with the most recent change of -$18.84 million (-11.68%) on September 30, 2024.
- Over the past year, ELTX quarterly retained earnings has dropped by -$46.84 million (-35.15%).
- ELTX quarterly retained earnings is now -207.38% below its all-time high of -$58.59 million, reached on March 31, 2021.
Performance
ELTX Quarterly Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Retained Earnings Formula
Retained Earnings = Retained Earnings (start of the period) + Net Income − Dividends Paid
ELTX Retained Earnings Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -32.9% | -35.1% |
| 3 y3 years | -171.4% | - |
| 5 y5 years | -287.6% | - |
ELTX Retained Earnings Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -80.5% | at low | -207.4% | at low |
| 5 y | 5-year | -287.6% | at low | -207.4% | at low |
| alltime | all time | -287.6% | at low | -207.4% | at low |
Elicio Therapeutics Retained Earnings History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -$180.10 M(+11.7%) |
| Jun 2024 | - | -$161.26 M(+4.7%) |
| Mar 2024 | - | -$154.03 M(+8.3%) |
| Dec 2023 | -$142.20 M | -$142.20 M(+6.7%) |
| Sep 2023 | - | -$133.25 M(+8.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2023 | - | -$122.60 M(+14.6%) |
| Dec 2022 | -$107.01 M(+35.8%) | -$107.01 M(+82.6%) |
| Dec 2021 | -$78.80 M(+50.4%) | - |
| Mar 2021 | - | -$58.59 M |
| Dec 2020 | -$52.40 M(+42.8%) | - |
| Dec 2019 | -$36.69 M | - |
FAQ
- What is Elicio Therapeutics annual retained earnings?
- What is the all time high annual retained earnings for Elicio Therapeutics?
- What is Elicio Therapeutics annual retained earnings year-on-year change?
- What is Elicio Therapeutics quarterly retained earnings?
- What is the all time high quarterly retained earnings for Elicio Therapeutics?
- What is Elicio Therapeutics quarterly retained earnings year-on-year change?
What is Elicio Therapeutics annual retained earnings?
The current annual retained earnings of ELTX is -$142.20 M
What is the all time high annual retained earnings for Elicio Therapeutics?
Elicio Therapeutics all-time high annual retained earnings is -$36.69 M
What is Elicio Therapeutics annual retained earnings year-on-year change?
Over the past year, ELTX annual retained earnings has changed by -$35.20 M (-32.89%)
What is Elicio Therapeutics quarterly retained earnings?
The current quarterly retained earnings of ELTX is -$180.10 M
What is the all time high quarterly retained earnings for Elicio Therapeutics?
Elicio Therapeutics all-time high quarterly retained earnings is -$58.59 M
What is Elicio Therapeutics quarterly retained earnings year-on-year change?
Over the past year, ELTX quarterly retained earnings has changed by -$46.84 M (-35.15%)